Company Quick10K Filing
Agilysys
10-K 2021-03-31 Filed 2021-05-21
10-Q 2020-12-31 Filed 2021-01-27
10-Q 2020-09-30 Filed 2020-10-28
10-Q 2020-06-30 Filed 2020-07-31
10-K 2020-03-31 Filed 2020-05-22
10-Q 2019-12-31 Filed 2020-01-29
10-Q 2019-09-30 Filed 2019-10-30
10-Q 2019-06-30 Filed 2019-07-29
10-K 2019-03-31 Filed 2019-05-24
10-Q 2018-12-31 Filed 2019-01-30
10-Q 2018-09-30 Filed 2018-10-26
10-Q 2018-06-30 Filed 2018-08-02
10-K 2018-03-31 Filed 2018-05-25
10-Q 2017-12-31 Filed 2018-01-26
10-Q 2017-09-30 Filed 2017-11-02
10-Q 2017-06-30 Filed 2017-08-04
10-K 2017-03-31 Filed 2017-06-02
10-Q 2016-12-31 Filed 2017-02-09
10-Q 2016-09-30 Filed 2016-11-09
10-Q 2016-06-30 Filed 2016-08-04
10-K 2016-03-31 Filed 2016-06-10
10-Q 2015-09-30 Filed 2015-11-05
10-Q 2015-06-30 Filed 2015-08-06
10-K 2015-03-31 Filed 2015-06-05
10-Q 2014-12-31 Filed 2015-02-05
10-Q 2014-09-30 Filed 2014-11-06
10-Q 2014-06-30 Filed 2014-08-07
10-K 2014-03-31 Filed 2014-06-04
10-Q 2013-12-31 Filed 2014-02-07
10-Q 2013-09-30 Filed 2013-11-07
10-Q 2013-06-30 Filed 2013-08-02
10-K 2013-03-31 Filed 2013-06-14
10-Q 2012-12-31 Filed 2013-02-04
10-Q 2012-09-30 Filed 2012-11-07
10-Q 2012-06-30 Filed 2012-08-09
10-K 2012-03-31 Filed 2012-06-12
10-Q 2011-12-31 Filed 2012-02-09
10-Q 2011-09-30 Filed 2011-11-09
10-Q 2011-06-30 Filed 2011-08-09
10-K 2011-03-31 Filed 2011-06-14
10-Q 2010-12-31 Filed 2011-02-08
10-Q 2010-09-30 Filed 2010-11-05
10-Q 2010-06-30 Filed 2010-08-09
10-K 2010-03-31 Filed 2010-06-11
10-Q 2009-12-31 Filed 2010-02-08
8-K 2021-01-26 Earnings, Exhibits
8-K 2021-01-14 Regulation FD, Exhibits
8-K 2020-11-19
8-K 2020-10-27
8-K 2020-10-09
8-K 2020-09-17
8-K 2020-07-27
8-K 2020-07-23
8-K 2020-07-02
8-K 2020-06-30
8-K 2020-05-26
8-K 2020-05-24
8-K 2020-05-22
8-K 2020-05-21
8-K 2020-05-11
8-K 2020-05-11
8-K 2020-04-08
8-K 2020-02-10
8-K 2020-01-28
8-K 2019-12-05
8-K 2019-09-30
8-K 2019-08-09
8-K 2019-08-07
8-K 2019-07-25
8-K 2019-06-24
8-K 2019-05-30
8-K 2019-05-16
8-K 2019-04-08
8-K 2019-02-21
8-K 2019-01-24
8-K 2019-01-16
8-K 2018-11-07
8-K 2018-10-25
8-K 2018-09-12
8-K 2018-08-09
8-K 2018-08-01
8-K 2018-05-24
8-K 2018-03-20
8-K 2018-03-13
8-K 2018-01-25
8-K 2018-01-25

Agilysys Financials

AGYS Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
Bioquest Corp (BQST)
11 Good Energy (ELVN)
BriaCell Therapeutics Corp. (BCTXW)
1347 Capital Corp (TFSC)
DD3 Acquisition Corp. II (DDMXW)
8i Acquisition 2 Corp. (LAX)
Acumen Pharmaceuticals, Inc. (ABOS)
Aerovate Therapeutics, Inc. (AVTE)
Ameren Illinois Co (AILNP)
Frontier Investment Corp (FICV)
Gobi Acquisition Corp. (GOBI)
HEALTH REVENUE ASSURANCE HOLDINGS, INC. (HRAA)
Ocean Biomedical, Inc. (OCEA)
SERA PROGNOSTICS, INC. (SERA)
Xiaoju Kuaizhi Inc. (DIDI)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
COMSovereign Holding Corp. (COMSW)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash51,67593,66244,06197,58780,33677,32779,83882,93170,611100,43296,35799,56677,86267,16869,10975,06766,03462,10165,65255,31251,62952,71343,40838,53237,61535,07632,90436,99537,23338,915
Accounts Receivable130,52230,11430,05532,53134,65633,71051,92345,62618,75719,61924,45923,61522,30223,51921,24825,48119,24217,03420,90722,01717,31216,13915,30815,59818,73014,74214,74616,38920,30618,96333,64027,00025,69023,117
Inventory25,68613,64911,69415,71015,65212,16418,19212,2391,4621,6662,4084819057206436415231,2192,3312,6922,2802,3172,0842,2111,9152,2992,1311,9991,7651,6781,5662,0441,483954
PP&E107,26799,929101,01416,50415,91615,39615,23137,49314,39414,19013,85033,41611,81813,67013,74322,07612,26713,77713,85724,00813,97614,00113,82928,50216,86216,85817,76033,56217,11316,35515,27836,02615,06715,290
Assets301,103215,122198,773204,139185,308177,696203,771196,964181,542184,479187,759190,895178,690176,596174,617181,525170,640169,235183,877185,157175,126171,365171,705167,305164,245155,697155,918157,207162,228153,626167,433163,591167,448163,795
Accounts Payable94,55015,91020,60324,93823,81521,04842,29830,1779,8049,38911,34111,0739,63610,14410,33316,5869,0538,51411,4027,7617,5019,2508,6238,7028,9938,8608,1758,4009,0337,3816,4314,7184,4698,836
Long-Term Debt
Liabilities156,02469,87866,92989,70172,37464,59390,55083,10866,48348,54153,66858,02247,70145,93945,90857,33746,24744,24759,65361,68453,65751,85853,99953,63652,33046,26947,70448,77652,47946,65263,32862,96967,52565,430
Stockholders' Equity145,079145,244131,844114,438112,934113,103113,221113,856115,059135,938134,091132,873130,989130,657128,709124,188124,393124,988124,224123,473121,469119,507117,706113,669111,915109,428108,214108,431109,749106,974104,105100,62299,92398,365
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue151,64353,58851,58224,77051,64654,24667,21163,03724,50026,57926,00727,75023,74626,31824,74228,70827,49129,64431,30731,92430,95332,67633,44830,60233,86530,12931,3107,94134,00734,20336,01436,61838,38940,722
Cost of Revenue113,21031,97231,65031,21531,26832,16543,76238,7758,3619,16310,3009,3979,0729,64910,6133,41711,09212,05314,7994,04414,76216,79717,20715,12717,19514,75915,68215,31116,11816,45417,36717,02318,37520,505
Gross Profit38,43321,61619,93220,81620,37822,08123,44924,26216,13917,41615,70716,66014,67416,66914,12914,61016,39917,59116,50817,60716,19115,87916,24115,47516,67015,37015,62816,74417,88917,74918,64719,59520,01420,217
R&D6,2859,3728,6128,4396,4767,0056,0745,6575,8656,1916,6706,5906,2686,7846,9696,6676,8556,9466,8478,4016,6266,8127,2697,2287,08910,15110,05910,51810,06410,778
SG&A41,42524,46023,74412,73011,28512,62012,6308,0579,6279,3817,7449,00210,3898,87110,2499,63810,51710,13511,26510,50710,2538,67811,26011,9309,76810,39210,01219,52821,55322,52511,35421,55823,098
Tax-1,041-2,806-1,353-1,798-47-4119-215-105-501-1,154-731-79581-62-277-24-19-561064282129-1678105-1,623-1,812-4953182352541
Net Income-4,7897,249-6,509-16,978-1,7934,3655163301,31620,452-2,662-2,009-2,229-694-2,715-5,426-185-370-1,673-1,538-2,297-2,400-1,737-5,287-2,958-3,248-1,934-212-1,736-3,791-4,048-3,589-1,575-2,918
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-21,23416,126-4,661-11,929-19,807-1,9654,3846,683-5,679-2,2141578,594-8,187-1,3172,0355,283-1,8651,6418,538-1,096-1,0198355,577-1,960-484-1,1643,7464,776-1,363-1,3855,522-1,9133,147
Cash Investing-79860,772-38,37238,7372,817-917-1,689-3,264-5,01431,999-4,331-4,968-13,157-9,47385913-6,805-5,427-4,938-3,843-3,689-4,408-4,405-1,363-5,117-3,468-4,003-2,497-2,878-646-1,708-573-1,369
Cash Financing-705-7,493-5,870-1,345-171-295-160-251-594-18103-374-386925-112-422-33-9-113-567-90-30-296-284-702-525-91-1,028-37